ABT-239
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
4-(2-{2-[(2R)-2-Methylpyrrolidin-1-yl]ethyl}-
benzofuran-5-yl)benzonitrile |
|
Identifiers | |
CAS Number | 460746-46-7 460746-51-4 (racemic) 460749-29-5 (S-isomer) |
PubChem | CID: 9818903 |
IUPHAR/BPS | 1218 |
ChemSpider | 7994652 |
ChEMBL | CHEMBL351231 |
Chemical data | |
Formula | C22H22N2O |
Molecular mass | 330.42 g/mol |
|
|
|
|
(verify) |
ABT-239 is an H3-receptor inverse agonist developed by Abbott. It has stimulant and nootropic effects, and has been investigated as a treatment for ADHD, Alzheimer's disease, and schizophrenia.[1][2][3][4] ABT-239 is more active at the human H3 receptor than comparable agents such as thioperamide, ciproxifan, and cipralisant. It was ultimately dropped from human trials after showing the dangerous cardiac side effect of QT prolongation,[5] but is still widely used in animal research into H3 antagonists / inverse agonists.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
- 4-(2-(2-(2-methyl-1-pyrrolidinyl)ethyl)-1-benzofuran-5-yl)benzonitrile at the US National Library of Medicine Medical Subject Headings (MeSH)
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Nootropics
- H3 receptor antagonists
- Nitriles
- Benzofurans
- Pyrrolidines
- Nervous system drug stubs